Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-020971
Filing Date
2014-05-14
Accepted
2014-05-14 17:07:40
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2014 form10q.htm 10-Q 974908
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11363
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11419
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6560
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6557
  Complete submission text file 0001140361-14-020971.txt   10874348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rnn-20140331.xml EX-101.INS 2390194
7 XBRL TAXONOMY EXTENSION SCHEMA rnn-20140331.xsd EX-101.SCH 62385
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20140331_cal.xml EX-101.CAL 47074
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20140331_def.xml EX-101.DEF 133528
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20140331_lab.xml EX-101.LAB 374471
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20140331_pre.xml EX-101.PRE 316475
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 14842426
SIC: 2834 Pharmaceutical Preparations